Section 13-3501 – Definitions

    (a)    In this subtitle the following words have the meanings indicated.     (b)    “Co–prescribing” means, with respect to an opioid overdose reversal drug, the practice of prescribing the drug in conjunction with an opioid prescription for a patient at an elevated risk of overdose.     (c)    “Opioid overdose reversal drug” means naloxone or a similarly acting and equally safe drug […]

Section 13-3502 – Establishment of Guidelines for Co-Providing Opioid Overdose Reversal Drugs

    (a)    The Secretary shall establish guidelines for the co–prescribing of opioid overdose reversal drugs that are applicable to all licensed health care providers in the State who are authorized by law to prescribe a monitored prescription drug, as defined in § 21–2A–01 of this article.     (b)    The guidelines established under subsection (a) of this section shall address […]